Aquaporin-0-protein interactions elucidated by crosslinking mass spectrometry.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): O'Neale CV;O'Neale CV; Tran MH; Tran MH; Schey KL; Schey KL
  • Source:
    Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2024 Oct 01; Vol. 727, pp. 150320. Date of Electronic Publication: 2024 Jun 27.
  • Publication Type:
    Journal Article; Research Support, N.I.H., Extramural
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Elsevier Country of Publication: United States NLM ID: 0372516 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1090-2104 (Electronic) Linking ISSN: 0006291X NLM ISO Abbreviation: Biochem Biophys Res Commun Subsets: MEDLINE
    • Publication Information:
      Publication: <2002- >: San Diego, CA : Elsevier
      Original Publication: New York, Academic Press.
    • Subject Terms:
    • Abstract:
      Aquaporin-0 (AQP0) constitutes 50 % of the lens membrane proteome and plays important roles in lens fiber cell adhesion, water permeability, and lens transparency. Previous work has shown that specific proteins, such as calmodulin (CaM), interact with AQP0 to modulate its water permeability; however, these studies often used AQP0 peptides, rather than full-length protein, to probe these interactions. Furthermore, the specific regions of interaction of several known AQP0 interacting partners, i.e. αA and αB-crystallins, and phakinin (CP49) remain unknown. The purpose of this study was to use crosslinking mass spectrometry (XL-MS) to identify interacting proteins with full-length AQP0 in crude lens cortical membrane fractions and to determine the specific protein regions of interaction. Our results demonstrate, for the first time, that the AQP0 N-terminus can engage in protein interactions. Specific regions of interaction are elucidated for several AQP0 interacting partners including phakinin, α-crystallin, connexin-46, and connexin-50. In addition, two new interacting partners, vimentin and connexin-46, were identified.
      Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Kevin L. Schey reports financial support was provided by National Institutes of Health. Carla O'Neale reports financial support was provided by National Institutes of Health. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
      (Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)
    • References:
      Exp Eye Res. 2008 Jul;87(1):9-21. (PMID: 18501347)
      J Clin Invest. 2009 Jul;119(7):1837-48. (PMID: 19587458)
      Exp Eye Res. 2017 Jun;159:23-29. (PMID: 28259670)
      J Cell Sci. 1996 Feb;109 ( Pt 2):447-56. (PMID: 8838668)
      Biochem Biophys Res Commun. 2009 May 22;383(1):54-7. (PMID: 19336226)
      Curr Eye Res. 1991 Sep;10(9):839-49. (PMID: 1790714)
      Anal Chem. 2003 Feb 1;75(3):663-70. (PMID: 12585499)
      J Gen Physiol. 2004 May;123(5):573-80. (PMID: 15078916)
      Nature. 2018 Dec;564(7736):372-377. (PMID: 30542154)
      Protein Sci. 2014 Jun;23(6):747-59. (PMID: 24639379)
      Int J Mol Sci. 2022 Aug 25;23(17):. (PMID: 36077012)
      IUBMB Life. 2006 Nov;58(11):632-41. (PMID: 17085382)
      Cell Stress Chaperones. 2017 Jul;22(4):627-638. (PMID: 28391594)
      Proc Natl Acad Sci U S A. 2014 Apr 22;111(16):E1562-70. (PMID: 24711386)
      J Am Soc Mass Spectrom. 2003 Aug;14(8):834-50. (PMID: 12892908)
      J Mol Biol. 2004 Sep 24;342(4):1337-45. (PMID: 15351655)
      Exp Cell Res. 2007 Jun 10;313(10):2180-8. (PMID: 17490642)
      Mol Biol Cell. 2014 Mar;25(6):776-90. (PMID: 24478454)
      Protein Sci. 2023 Apr;32(4):e4606. (PMID: 36810829)
      Biochemistry. 2006 Nov 21;45(46):13847-54. (PMID: 17105203)
      Biochem Biophys Res Commun. 1989 Jan 16;158(1):319-25. (PMID: 2912453)
      Biochim Biophys Acta Biomembr. 2022 Feb 1;1864(2):183837. (PMID: 34890582)
      Biochim Biophys Acta. 2012 Feb;1822(2):120-9. (PMID: 22120592)
      Biochem Biophys Res Commun. 2009 Dec 18;390(3):1034-9. (PMID: 19857466)
      Invest Ophthalmol Vis Sci. 2010 Mar;51(3):1565-74. (PMID: 19875662)
      PLoS One. 2013 Nov 27;8(11):e80404. (PMID: 24312215)
      Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10449-53. (PMID: 1438232)
      EMBO J. 2005 Nov 16;24(22):3834-45. (PMID: 16270034)
      Biochemistry. 1989 Apr 4;28(7):2974-9. (PMID: 2500966)
      Mol Vis. 2008 Apr 25;14:815-22. (PMID: 18449355)
      Gene. 1997 Nov 12;201(1-2):11-20. (PMID: 9409766)
      J Membr Biol. 2007 Mar;216(1):1-16. (PMID: 17568975)
      Cell Stress Chaperones. 2020 Jul;25(4):639-654. (PMID: 32383140)
      J Biol Chem. 2005 Feb 18;280(7):5281-9. (PMID: 15542604)
      Biochemistry. 2006 Mar 7;45(9):3069-76. (PMID: 16503662)
      EMBO Mol Med. 2012 Jan;4(1):15-26. (PMID: 22095752)
      Invest Ophthalmol Vis Sci. 2006 Apr;47(4):1562-70. (PMID: 16565393)
      J Cell Sci. 2017 Sep 1;130(17):2914-2925. (PMID: 28754689)
      J Biol Chem. 1998 Mar 27;273(13):7604-9. (PMID: 9516464)
      J Biol Chem. 2005 Jun 10;280(23):22081-90. (PMID: 15802270)
      Sci Rep. 2017 Jul 13;7(1):5298. (PMID: 28706245)
      Invest Ophthalmol Vis Sci. 2004 Mar;45(3):863-71. (PMID: 14985303)
      J Cell Sci. 2011 Jan 15;124(Pt 2):198-206. (PMID: 21172802)
      J Biol Chem. 2000 Mar 10;275(10):6777-82. (PMID: 10702234)
      Biochemistry. 2008 Jan 8;47(1):339-47. (PMID: 18081321)
      Int J Mol Sci. 2021 Aug 26;22(17):. (PMID: 34502121)
      Nat Struct Mol Biol. 2013 Sep;20(9):1085-92. (PMID: 23893133)
      Proc Natl Acad Sci U S A. 2004 Sep 28;101(39):14045-50. (PMID: 15377788)
      J Cell Biochem. 2008 May 1;104(1):51-8. (PMID: 18004741)
      Exp Eye Res. 2009 Feb;88(2):165-72. (PMID: 19071112)
      Mol Vis. 2011;17:3191-9. (PMID: 22194645)
      Biochem J. 2024 Jan 10;481(1):17-32. (PMID: 38032258)
      Chem Rev. 2022 Apr 27;122(8):7500-7531. (PMID: 34797068)
      Nat Genet. 1996 Feb;12(2):212-5. (PMID: 8563764)
      Invest Ophthalmol Vis Sci. 2011 Jul 07;52(8):5079-87. (PMID: 21642618)
      J Cell Sci. 2004 Feb 29;117(Pt 6):871-80. (PMID: 14762116)
      Faraday Discuss. 2018 Sep 28;209(0):35-54. (PMID: 29972182)
      Annu Rev Phys Chem. 2021 Apr 20;72:143-163. (PMID: 33321054)
      Genes Dev. 2007 Jul 1;21(13):1581-97. (PMID: 17606637)
      J Cell Sci. 1995 Apr;108 ( Pt 4):1397-406. (PMID: 7615661)
    • Grant Information:
      F31 EY032348 United States EY NEI NIH HHS; P30 EY008126 United States EY NEI NIH HHS; R01 EY013462 United States EY NEI NIH HHS; U01 AI150739 United States AI NIAID NIH HHS
    • Contributed Indexing:
      Keywords: Aquaporin-0; Crosslinking; Lens protein; Mass spectrometry; Membrane protein; Protein interaction
    • Accession Number:
      0 (Aquaporins)
      0 (aquaporin 0)
      0 (Eye Proteins)
      0 (Connexins)
      0 (connexin 50)
      0 (Vimentin)
      0 (Cross-Linking Reagents)
      0 (alpha-Crystallins)
    • Publication Date:
      Date Created: 20240704 Date Completed: 20240721 Latest Revision: 20241116
    • Publication Date:
      20241116
    • Accession Number:
      PMC11563185
    • Accession Number:
      10.1016/j.bbrc.2024.150320
    • Accession Number:
      38963984